Filing Flows › Moderna (MRNA) › Net product sales revenue
Moderna (MRNA) Net product sales revenue by quarter
Moderna's Net product sales revenue was $1.3B in Q3 2026 (third quarter 2026), up 14-fold from Q2 2026. Over the last 5 quarters it ranged from $86.0M (Q1 2025) to $1.3B (Q3 2026).
| Quarter | Net product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.3B | 14× | — |
| Q2 2026 | $94.0M | -73% | — |
| Q1 2026 | $352M | -46% | +309% |
| Q4 2025 | $646M | +651% | — |
| Q1 2025 | $86.0M | — | — |
Q3 2026 at a glance
Moderna, Q3 2026: revenue $1.3B (+29% year over year), operating margin 9.9%, net earnings $162M, operating cash flow −$1.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is Moderna's Net product sales revenue?
Moderna's Net product sales revenue was $1.3B in Q3 2026 (third quarter 2026), up 14-fold from Q2 2026.
How has Moderna's Net product sales revenue changed?
Over the last 5 quarters it ranged from $86.0M (Q1 2025) to $1.3B (Q3 2026).